Senate Finance Committee Chairman Wyden Renews Call for PBM Reforms Needed to Lower Drug Prices, Increase Access Following New FTC Report
July 10, 2024
July 10, 2024
WASHINGTON, July 10 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following statement on July 9, 2024
* * *
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Federal Trade Commission (FTC) released an interim report on pharmacy benefit managers (PBMs) and their impact on the access and affordability of prescription drugs.
"Middlemen are right at the heart of Americans' frustration w . . .
* * *
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Federal Trade Commission (FTC) released an interim report on pharmacy benefit managers (PBMs) and their impact on the access and affordability of prescription drugs.
"Middlemen are right at the heart of Americans' frustration w . . .